Early trial findings demonstrate the efficacy of FGFR inhibitors and PARP/ATR inhibitor combos in a variety of tumor types.

Published Date: 19 Apr 2023

At the American Association for Cancer Research (AACR) Annual Meeting 2023, researchers from The University of Texas MD Anderson Cancer Center presented promising results from a number of clinical trials.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Targeted radiation therapy shows near-complete response in rare sarcoma patients

2.

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

3.

Germline Profiling May Improve Risk Stratification in t-MNs

4.

Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.

5.

Scientists call into question safety of potential new anticancer treatment


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot